Liver diseases
Information
- Disease name
- Liver diseases
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03089840 | Active, not recruiting | Phase 1/Phase 2 | Normothermic Liver Preservation Trial | February 24, 2017 | June 30, 2025 |
| NCT03353701 | Active, not recruiting | N/A | 30-to-90 Day Challenge: Effects of Alcohol Cessation on Health Outcomes | December 11, 2017 | August 1, 2023 |
| NCT03221127 | Active, not recruiting | Kuopio Ischaemic Heart Disease Risk Factor Study (Nutrition Component) | March 1, 1984 | December 31, 2052 | |
| NCT05182099 | Active, not recruiting | N/A | High Resolution HBA-MRI Using Deep Learning Reconstruction | January 10, 2022 | September 30, 2023 |
| NCT05946330 | Active, not recruiting | N/A | Nutritional Intervention IN Nash NON-ALCOHOLIC (NAFLD). | February 22, 2023 | July 31, 2024 |
| NCT05135767 | Active, not recruiting | N/A | Biobehavioral Pathways Underlying Alcohol Use and Health | February 28, 2022 | November 30, 2023 |
| NCT02908048 | Active, not recruiting | Extracellular RNA Markers of Liver Disease and Cancer | July 2014 | July 2026 | |
| NCT03522688 | Active, not recruiting | Phase 4 | Impact of Dexmedetomidine on Acute Kidney Injury Following Living Donor Liver Transplantation | July 11, 2017 | July 7, 2024 |
| NCT03072667 | Approved for marketing | Omegaven for Compassionate Use in the Treatment of Parenteral Nutrition-Associated Liver Disease | |||
| NCT00222664 | Completed | Phase 4 | Qidong Hepatitis B Intervention Study | September 1983 | December 2004 |
| NCT00267670 | Completed | Phase 2/Phase 3 | Pentoxifylline/Nonalcoholic Steatohepatitis (NASH) Study: The Effect of Pentoxifylline on NASH | March 2005 | September 2009 |
| NCT00000583 | Completed | Phase 3 | Hepatitis B Vaccine Clinical Trial | November 1978 | June 1980 |
| NCT00365248 | Completed | Phase 3 | TachoSil Paediatric Liver Trial (TC-019-IN) | October 2005 | May 2008 |
| NCT00382668 | Completed | A Study of Dasatinib to See How Liver Impaired and Healthy Subjects Process and React to the Study Drug | October 2006 | August 2007 | |
| NCT00426153 | Completed | Phase 2/Phase 3 | Octreotide in Severe Polycystic Liver Disease | January 2007 | October 2008 |
| NCT00488917 | Completed | Sepsis, Endothelial Function, and Lipids in Critically Ill Patients With Liver Failure (the SELLIFA Study) | June 2007 | August 2009 | |
| NCT00523562 | Completed | N/A | Effects of Macronutrients on Hepatic Lipids, Plasma Triglycerides, and Insulin Sensitivity | July 2006 | January 2009 |
| NCT00526331 | Completed | Phase 4 | Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative Therapy | August 2007 | September 2008 |
| NCT00565097 | Completed | Phase 2/Phase 3 | Lanreotide as Treatment of Polycystic Livers | October 2007 | |
| NCT04055870 | Completed | Efficacy, Safety, and Adequacy of EUS-guided Liver Biopsy | August 21, 2017 | October 30, 2020 | |
| NCT04067349 | Completed | N/A | Physical Recovery After Laparoscopic vs. Open Liver Resection | April 6, 2017 | April 14, 2019 |
| NCT04341012 | Completed | Breath Analysis Based Disease Biomarkers of COVID-19 and Other Diseases | September 10, 2019 | September 3, 2021 | |
| NCT04255082 | Completed | Mindfulness and Shared Decision Making | August 15, 2018 | July 20, 2022 | |
| NCT00000580 | Completed | Phase 3 | Interruption of Maternal-to-Infant Transmission of Hepatitis B by Means of Hepatitis B Immune Globulin | November 1975 | June 1986 |
| NCT04181502 | Completed | N/A | Ischemic Preconditioning at a Distance in Liver Surgery | June 16, 2019 | January 6, 2020 |
| NCT00011284 | Completed | Mechanisms of Inflammatory Liver Injury | November 2001 | ||
| NCT00063622 | Completed | Phase 3 | Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS) | January 2005 | September 2009 |
| NCT00148031 | Completed | Phase 4 | Improving Hepatitis C Treatment in Injection Drug Users | September 2003 | March 2007 |
| NCT00005304 | Completed | Delta Hepatitis and Liver Disease in Hemophiliacs | September 1986 | September 1991 | |
| NCT00005305 | Completed | Hepatitis Delta Infections in Hemophiliacs | September 1987 | September 1991 | |
| NCT04639115 | Completed | Phase 1 | A Phase 1, Multicenter, Open-Label Study to Evaluate the Effect of Mild or Moderate Hepatic Impairment on the Multiple-Dose Pharmacokinetics of Ozanimod | December 18, 2020 | April 6, 2022 |
| NCT04627012 | Completed | Lenvatinib Combined Anti-PD1 Antibody for the Advanced Hepatocellular Carcinoma | January 1, 2018 | July 1, 2023 | |
| NCT03784716 | Completed | N/A | Ketogenic Diet in Non-alcoholic Fatty Liver Disease | March 13, 2019 | February 10, 2022 |
| NCT04618692 | Completed | N/A | Biliary Anastomosis Using Surgical Loupe Versus Microscope in Living Donor Liver Transplantation | December 2, 2020 | March 30, 2023 |
| NCT03809559 | Completed | Repeatability and Reproducibility of Quantitative MRCP | July 19, 2018 | March 8, 2019 | |
| NCT04473482 | Completed | N/A | Michigan Alcohol Improvement Network- Alcohol Reduction and Treatment Trial | September 23, 2020 | June 30, 2022 |
| NCT00005306 | Completed | Natural History of Post-transfusion Non-A, Non-B Hepatitis | March 1988 | September 2001 | |
| NCT03833297 | Completed | Monitoring the HePAtological TOXicity of Drugs (HePATOX) | February 4, 2019 | April 4, 2023 | |
| NCT04465747 | Completed | Egyptian Liver Library: Rebuilding the Pyramid of Liver Disease Evidence in Egypt | January 2016 | January 2018 | |
| NCT03861819 | Completed | N/A | Feasibility of VIIT in Adults With NASH | January 1, 2018 | December 7, 2018 |
| NCT04462874 | Completed | Mean Systemic Filling Pressure Trends in Liver Transplant Recipients | July 15, 2020 | December 15, 2021 | |
| NCT03967067 | Completed | Risk Factors for Major Complications After Liver Resection | January 1, 2010 | December 31, 2016 | |
| NCT03969186 | Completed | N/A | Telehealth Intervention in Cirrhotics | October 11, 2017 | August 31, 2023 |
| NCT04407182 | Completed | Phase 2 | Safety and Efficacy of Viusid and Asbrip in Hospitalized Patients Infected by SARS-Cov-2 With COVID-19 | May 4, 2020 | October 1, 2020 |
| NCT03995537 | Completed | Monocytic Expression of HLA-DR After Liver Transplantation | February 26, 2020 | July 14, 2023 | |
| NCT04004273 | Completed | N/A | Diabetes, Exercise and Liver Fat (DELIVER) | October 30, 2018 | July 20, 2022 |
| NCT04375670 | Completed | COVID19-FOIE National Observatory | May 11, 2020 | May 31, 2022 | |
| NCT04022681 | Completed | Long-term Follow Up of Patients in the Birmingham and Lambeth Liver Evaluation Strategies (BALLETS) Study | December 1, 2005 | July 1, 2013 | |
| NCT04066153 | Completed | Patient Reported Unmet Needs for Function and Supportive Occupational- and Physiotherapy Rehabilitation Interventions | August 20, 2019 | November 8, 2019 | |
| NCT00659698 | Completed | Phase 4 | Effect of an Artificial Pancreas in Patients Undergoing Hepatic Resection | April 2007 | April 2008 |
| NCT00681499 | Completed | Quality of Life After Liver Resection | February 2008 | January 2014 | |
| NCT00701376 | Completed | N/A | Hepatic Effects of Gastric Bypass Surgery | June 2008 | September 2014 |
| NCT05857644 | Completed | Phase 1 | A Study to Compare How the Study Medicine (PF-07923568) is Processed in Participants With Different Levels of Loss of Liver Function to Healthy Participants. | June 7, 2023 | February 7, 2024 |
| NCT00738348 | Completed | N/A | Effect of Perioperative Sivelstat Administration for Liver Resection | April 2007 | July 2008 |
| NCT05731908 | Completed | Phase 1 | A Study to Test How BI 690517 is Taken up in the Body of People With and Without Liver Problems | February 21, 2023 | April 13, 2023 |
| NCT00861601 | Completed | Phase 2 | Phase 2, Pharmacokinetics Study of Eltrombopag in Japanese Thrombocytopenic Subjects With Chronic Liver Disease | January 2009 | August 2009 |
| NCT00931060 | Completed | N/A | Effects of Branched-Chain Amino Acids on Muscle Ammonia Metabolism in Patients With Cirrhosis and Healthy Subjects | November 2007 | June 2009 |
| NCT00938795 | Completed | N/A | Uncertainty Management Intervention | February 2010 | September 2013 |
| NCT00940537 | Completed | Magnetic Resonance Spectroscopy (MRS) Validation Study in Individuals With Nonalcoholic Fatty Liver Disease (NAFLD) | June 2009 | March 2010 | |
| NCT00948220 | Completed | Phase 4 | Influence of Antiviral Therapy on Bone Mineral Density and Metabolism in Patients With Chronic Hepatitis C | July 2003 | March 2008 |
| NCT01148706 | Completed | Phase 4 | Effectiveness of ActiSight™ Needle Guidance System in Patients Undergoing CT-Guided Procedures | July 2010 | September 2012 |
| NCT01163240 | Completed | Epidemiological Study in Children and Adolescents With Chronic Hepatitis B | June 2009 | ||
| NCT05471596 | Completed | Prospective Analysis of In Vivo Laparoscopic Microwave Ablation Thermodynamics | February 14, 2022 | November 17, 2023 | |
| NCT01284049 | Completed | N/A | Evaluation of OMEGAVEN 10%® (n-3 EFA Lipid Emulsion) in Home Parenteral Nutrition-associated Liver Disease | November 2011 | March 2016 |
| NCT01298063 | Completed | Phase 1 | Influence of Mild and Moderate Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of Various Doses of Afatinib | February 2011 | |
| NCT01381432 | Completed | Special Drug Use Investigation for IMURAN (Azathioprine) Tablet (Pulmones Transplantation) | December 2004 | May 2011 | |
| NCT01390766 | Completed | Drug Use Investigation for IMURAN (Azathioprine) Tablet (Hepatic Transplantation) | August 2002 | May 2011 | |
| NCT01394497 | Completed | Phase 2 | Use of N-Acetylcysteine During Liver Procurement | December 2006 | July 2009 |
| NCT05392452 | Completed | N/A | Fully Closed-Loop Insulin Delivery in Abdominal Surgery (CLAB) | August 9, 2022 | November 13, 2023 |
| NCT01458756 | Completed | Study of Psychological Defense Mechanisms Used by Liver Transplant Patients | December 2006 | October 2016 | |
| NCT05385952 | Completed | N/A | GATT-Patch Versus TachoSil in Liver Surgery | August 4, 2022 | May 10, 2024 |
| NCT05383456 | Completed | The Visceral Adiposity Measurement and Observation Study | April 18, 2022 | October 30, 2023 | |
| NCT05367414 | Completed | N/A | Aromatherapy Massage for Itching Management in Liver Diseases | February 13, 2020 | June 23, 2021 |
| NCT05296733 | Completed | Phase 1 | A Study to (1) Compare How BI 456906 is Taken up in the Body of Healthy People and People With Liver Problems and (2) Find Out How People With Overweight and Obesity, With and Without Liver Problems, Tolerate Different Doses of BI 456906 | April 27, 2022 | December 29, 2023 |
| NCT01619475 | Completed | Adult-to-Adult Living Donor Transplant Cohort Study | February 2011 | August 2014 | |
| NCT05295537 | Completed | N/A | Percutaneous Versus Endoscopic Ultrasound-guided Liver Biopsy (PEREUS) | January 19, 2022 | December 1, 2022 |
| NCT01870388 | Completed | Phase 1 | A Pharmacokinetic Study of Baricitinib in Participants With Liver Disease | June 2013 | July 2013 |
| NCT01922791 | Completed | N/A | Nutrition and Pregnancy Intervention Study | October 2013 | March 2023 |
| NCT02073435 | Completed | A2ALL-Patients Safety System Improvements in Living Donor Liver Transplantation | October 2010 | April 2018 | |
| NCT02121860 | Completed | Phase 1 | PK and PD Study of IDN-6556 in Subjects With Hepatic Impairment and Matched Healthy Volunteers | April 2014 | July 2014 |
| NCT02171832 | Completed | Phase 1 | Single Dose of BI 1744 CL in Patients With Mild and Moderate Hepatic Impairment Compared to Subjects With Normal Hepatic Function | July 2009 | |
| NCT05244720 | Completed | N/A | Evaluation of Liver Disease in Individuals Attending Alcohol Abuse Treatment - a Randomized Controlled Pilot Trial | November 1, 2021 | September 30, 2022 |
| NCT02279524 | Completed | Phase 2 | A Clinical Trial to Evaluate the Efficacy and Safety of Two Aramchol Doses Versus Placebo in Patients With NASH | April 29, 2015 | May 22, 2018 |
| NCT02337673 | Completed | Screening of Postoperative Pulmonary Complications by Electrical Impedance Tomography | May 2014 | March 2016 | |
| NCT02489045 | Completed | Phase 4 | Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension | April 6, 2015 | March 31, 2019 |
| NCT02533193 | Completed | N/A | Enhanced Recovery After Surgery Protocal Versus Traditional Care in Laparoscopic Hepatectomy | August 2015 | August 2016 |
| NCT02601820 | Completed | The Patient-Reported Outcomes Project of HCV-TARGET | November 2015 | July 2018 | |
| NCT05194553 | Completed | Identification and Characterization of NAFLD in Turkey | February 15, 2022 | June 15, 2023 | |
| NCT05182983 | Completed | Tongue Image Database and Diagnostic Model for Digestive Tract Disease Diagnosis | November 15, 2020 | April 25, 2022 | |
| NCT02686762 | Completed | Phase 2 | Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis | January 26, 2016 | February 28, 2019 |
| NCT02758834 | Completed | Half-life of Plasma Phytosterols in Preterm Infants on Parenteral Nutrition | January 2014 | April 2016 | |
| NCT05167305 | Completed | The Second COVID-19 Wave: Collateral Impact on Patients of Liver Disease | December 22, 2021 | December 31, 2021 | |
| NCT02877602 | Completed | Patient Understanding of LiverMultiScan | February 2016 | December 2017 | |
| NCT02917408 | Completed | Retrospective Study About Primary Biliary Cholangitis During January 2001 to July 2016 at West China Hospital | September 2016 | January 2017 | |
| NCT05116826 | Completed | Phase 1 | Nitazoxanide Pharmacokinetic Parameters in Hepatic Impaired Patients | November 5, 2021 | April 13, 2022 |
| NCT02950142 | Completed | N/A | Evidence-based Laboratory Test Order Sets in Primary Care | December 1, 2017 | August 1, 2019 |
| NCT02967991 | Completed | N/A | 19 Versus 22-Gauge Needle for EUS-LB | August 2016 | July 2017 |
| NCT03031067 | Completed | N/A | Hypothermic Oxygenated Perfusion Versus Static Cold Storage for Marginal Graft | October 2016 | February 2018 |
| NCT05028842 | Completed | Effect of Lockdown During COVID 19 Pandemic on Liver Disease and Metabolic Parameters. | August 30, 2021 | September 6, 2021 | |
| NCT05018741 | Completed | Prognostic Factors After Liver Transplantation | January 1, 2002 | December 31, 2019 | |
| NCT03103997 | Completed | N/A | Wet Heparin for Obtaining Liver Tissue for EUS Guided Liver Biopsy | January 6, 2017 | June 30, 2018 |
| NCT03119025 | Completed | Phase 1/Phase 2 | Autologous Dendritic Cell Vaccine for Treatment of Patients With Chronic HCV-Infection | May 2015 | April 2018 |
| NCT03162302 | Completed | Liver Fat and Iron Quantification MRI | May 24, 2017 | May 3, 2021 | |
| NCT03169998 | Completed | Effect of Goal-directed Fluid Therapy on Postoperative Complications | January 1, 2017 | December 31, 2021 | |
| NCT05003050 | Completed | N/A | Energy Therapy and Meditation Based Practice for Sleep Difficulties | August 16, 2021 | March 10, 2022 |
| NCT03198104 | Completed | Assessing Kids for Liver Inflammation and Fibrosis Using Non-invasive MRI | April 1, 2016 | March 31, 2019 | |
| NCT04988633 | Completed | N/A | "CAP" Fetge Gras. Lifestyle Modification Program in Catalonia. | May 1, 2021 | July 31, 2022 |
| NCT03235414 | Completed | N/A | Normal Liver Stiffness by MR Elastography | February 19, 2018 | July 24, 2020 |
| NCT03245580 | Completed | N/A | Benign Liver Optimal Core Study (Tissue Acquisition Comparison in Benign Liver Disease) | March 8, 2018 | September 15, 2020 |
| NCT03260660 | Completed | Comparison of MR Elastography Methods Without and With Compressed Sensing | August 15, 2017 | December 1, 2017 | |
| NCT04977011 | Completed | N/A | Effectiveness of Music Intervention on Anxiety and Physiological Responses in Critical Ill Patient | January 2, 2019 | July 30, 2019 |
| NCT04931147 | Completed | Phase 1 | A 3-part Study to Evaluate Safety, Tolerability, Food Effect and Drug-drug Interactions of RXC007 in Healthy Volunteers | May 13, 2021 | March 8, 2023 |
| NCT03279419 | Completed | Thermal Imaging in Liver Disease. | September 1, 2019 | December 1, 2019 | |
| NCT03342560 | Completed | N/A | Beyond Confounders: Addressing Source of Measurement Variability and Error in Shear Wave Elastography | June 29, 2017 | August 30, 2018 |
| NCT04873609 | Completed | N/A | Electronic Record Assimilation and Subsequent Eradication of Hepatitis C | May 1, 2019 | April 30, 2020 |
| NCT04826666 | Completed | Intraoperative Phlebotomies and Bleeding in Liver Transplantation | March 31, 2021 | November 4, 2021 | |
| NCT03405909 | Completed | Standardized CEUS Algorithms for Diagnosis of HCC - Prospective German Multicenter Study | April 21, 2018 | April 6, 2019 | |
| NCT04816682 | Completed | Phase 4 | Silymarin in COVID-19 Patients Admitted to Hospital With Elevated Liver Enzymes | March 17, 2021 | December 30, 2021 |
| NCT03438916 | Completed | MRI to Assess the Effect of Non-selective Beta-blocker in Patients With Cirrhosis | April 1, 2017 | December 8, 2020 | |
| NCT03440164 | Completed | Superior Silybin Bioavailability in Healthy Volunteers | November 11, 2016 | December 15, 2016 | |
| NCT03443934 | Completed | Hemodynamic Alterations in Liver Cirrhosis Validated by Non-invasive MR Compared to Invasive Assessment | April 1, 2017 | April 21, 2021 | |
| NCT04789213 | Completed | Mortality, Morbidity and Risk Factors of Liver Retransplantation | March 10, 2021 | May 1, 2021 | |
| NCT03483272 | Completed | MRI to Assess the Effect of Terlipressin in Patients With Acute Hepatorenal Syndrome (HRS-AKI) | January 8, 2018 | April 21, 2021 | |
| NCT04782050 | Completed | N/A | Non-invasive Ultrasound Diagnosis of Chronic Liver Diseases in Hepatology Consultation | September 15, 2021 | August 29, 2022 |
| NCT03493204 | Completed | N/A | Tackling 30-day Readmissions in Patients With Cirrhosis: The SALTYFOOD Trial | April 24, 2018 | August 19, 2019 |
| NCT04778735 | Completed | N/A | Investigation of Mortality, Morbidity and Risk Factors After Pediatric Liver Transplantation | February 24, 2021 | April 4, 2022 |
| NCT03512184 | Completed | N/A | YMCA Diabetes Prevention Program for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) | January 3, 2018 | September 12, 2021 |
| NCT03512210 | Completed | Phase 4 | Monitoring SOF/VEL in Treatment Naïve, HCV Participants With Active Infection | October 22, 2018 | February 28, 2021 |
| NCT03518294 | Completed | N/A | NASH Fitness Intervention in Thrombosis Trial (NASHFit) | June 1, 2018 | March 24, 2021 |
| NCT04732689 | Completed | Intraoperative Hemodynamic Management and Postoperative Outcomes in Liver Transplantation | June 16, 2021 | July 31, 2023 | |
| NCT03584646 | Completed | N/A | Prehabilitation Intervention to Maximize Early Recovery (PRIMER) in Liver Transplantation | February 28, 2018 | October 1, 2022 |
| NCT03596697 | Completed | Phase 1 | A Study in Healthy Volunteers | July 9, 2019 | June 4, 2021 |
| NCT03598192 | Completed | N/A | The Effect and Safety of the Four Points Transversus Abdominis Plane Block | August 15, 2018 | July 30, 2020 |
| NCT03614039 | Completed | N/A | Effect of Probiotic and Smectite Gel on NAFLD | September 15, 2015 | April 20, 2016 |
| NCT04675775 | Completed | N/A | The BRAINFOOD Trial to Prevent Recurrent Hepatic Encephalopathy. | January 21, 2021 | March 5, 2023 |
| NCT03667157 | Completed | Phase 4 | Liver Function After Intravenous Methylprednisolone Administration | January 1, 2012 | October 30, 2016 |
| NCT00001001 | Completed | N/A | A Study of Zidovudine in HIV-Infected Patients With Liver Disease | May 1990 | |
| NCT03723317 | Completed | Associated Balance of Risk Score - Comprehensive Complication Index for the Prediction of Post-transplant Survival | January 15, 2018 | October 15, 2018 | |
| NCT04668664 | Completed | Endoscopic Ultrasound-Guided Portosystemic Pressure Gradient Measurements | April 5, 2021 | June 13, 2022 | |
| NCT04666558 | Completed | N/A | Heal-Me Personalized Online Nutrition and Exercise Routines | November 30, 2020 | August 31, 2022 |
| NCT03768141 | Completed | International Liver Surgery Outcomes Study | January 1, 2019 | March 31, 2020 | |
| NCT03768245 | Completed | N/A | School-Based Program On Metabolic Disease | July 1, 2016 | November 30, 2016 |
| NCT03772392 | Completed | Enhanced Recovery After Surgery for Hepatobiliary-Pancreatic Surgery | February 5, 2019 | November 5, 2019 | |
| NCT05224739 | Enrolling by invitation | Validate the Difficulty Scoring System and Develop a Novel Scoring System for Laparoscopic and Robotic Liver Resections | July 16, 2021 | November 16, 2024 | |
| NCT04234139 | Enrolling by invitation | Cohort/Ethics Study of Patients With Severe Alcoholic Hepatitis Undergoing Early Liver Transplantation | April 1, 2020 | December 31, 2025 | |
| NCT05082077 | Enrolling by invitation | Global Utilization And Registry Database for Improved preservAtion of doNor Livers | March 15, 2022 | January 2026 | |
| NCT03789825 | Enrolling by invitation | Population-based Study in Screening for Liver Fibrosis | May 1, 2018 | December 2023 | |
| NCT05556434 | Enrolling by invitation | Predicting Complications of Hepatolithiasis After Hepatectomy | July 1, 2011 | July 1, 2024 | |
| NCT03407833 | Enrolling by invitation | Physiologic and Functional Adaptations of Insulin Sensitive Tissues | February 13, 2018 | February 2028 | |
| NCT00263978 | No longer available | Defibrotide Compassionate Use for Patients With Life Threatening Veno-Occlusive Disease of the Liver | November 2005 | June 2009 | |
| NCT06291571 | Not yet recruiting | Assessment of Microorganisms and Host Response In Liver Diseases | June 1, 2024 | March 1, 2030 | |
| NCT06144112 | Not yet recruiting | Phase 4 | Prothrombin Complex Concentrate vs Fresh Frozen Plasma in Goal-directed Bleeding Management in Liver Transplantation Surgery | March 1, 2024 | April 1, 2025 |
| NCT06317181 | Not yet recruiting | N/A | Assessment of Liver Diseases Using a Deep-Learning Approach Based on Ultrasound RF-Data | April 2024 | December 2025 |
| NCT05723705 | Not yet recruiting | Impact of a European Training Program for Robotic Liver Surgery (LIVEROBOT) | April 2023 | December 2025 | |
| NCT05605717 | Not yet recruiting | Liver Fibrosis and Steatosis in dm Non Invasive Evaluation | November 1, 2022 | September 1, 2023 | |
| NCT05062967 | Not yet recruiting | Evaluation of Orthohepevirus C Infection as an Emerging Cause of Zoonotic Origin Disease | January 1, 2022 | December 1, 2024 | |
| NCT06068491 | Not yet recruiting | N/A | Integrating Veteran-Centered Care for Advanced Liver Disease (I-VCALD) | October 1, 2024 | September 30, 2027 |
| NCT06352177 | Not yet recruiting | N/A | Digital Therapeutic Lifestyle Intervention Program for Patients With MASLD | April 1, 2025 | August 1, 2030 |
| NCT06138821 | Not yet recruiting | Phase 4 | ESG vs GLP-1RA vs ESG + GLP-1RA in Patients With Obesity, NAFLD and Advanced Fibrosis: A Randomized Controlled Trial | July 2024 | December 2025 |
| NCT06124092 | Not yet recruiting | Outcomes of Children After Hospitalization in Intensive Care Unit | March 2024 | March 2029 | |
| NCT06269510 | Not yet recruiting | N/A | Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients | April 2025 | July 2027 |
| NCT04825470 | Not yet recruiting | N/A | Liver Transplantation for Unresectable GIST Liver Metastases | May 2022 | December 2025 |
| NCT05459155 | Not yet recruiting | N/A | Effect of Synapse Medicine Decision Support on Inpatient Pharmacist Efficacy and Efficiency | March 2023 | December 2023 |
| NCT05817994 | Not yet recruiting | Endoscopic Ultrasound Guided Liver Biopsy and Portal Pressure Registry | April 2023 | July 2023 | |
| NCT06353672 | Recruiting | N/A | A Study to Evaluate Safety and Feasibility of Robotic Liver Resection | December 1, 2020 | December 31, 2026 |
| NCT00345930 | Recruiting | DILIN - Prospective Study | September 2004 | July 31, 2028 | |
| NCT03692897 | Recruiting | An Observational Study of Patients With Chronic Hepatitis B (CHB) Infection | October 11, 2018 | January 2026 | |
| NCT03773887 | Recruiting | N/A | Comparison of Inflammatory Profiles and Regenerative Potential in Alcoholic Liver Disease | September 2015 | September 2027 |
| NCT03775837 | Recruiting | N/A | Effect of Panax Ginseng C.A. Mey Extract on Liver Function in Adults | December 1, 2018 | December 31, 2024 |
| NCT03813862 | Recruiting | Observational Pharmaco-Epidemiology Research & Analysis | December 1, 2013 | November 2027 | |
| NCT04181138 | Recruiting | Primary Sclerosing Cholangitis in Children | December 30, 2021 | May 2029 | |
| NCT04422223 | Recruiting | Prospective Cohort Study of Disease and Outcomes in Cirrhosis | November 1, 2019 | December 30, 2024 | |
| NCT04454463 | Recruiting | Nonalcoholic Fatty Liver Disease (NAFLD) Database 3 | November 13, 2020 | June 30, 2024 | |
| NCT04477967 | Recruiting | Design and Implementation of the Pediatric Liver Transplantation Biobank | October 1, 2018 | July 1, 2028 | |
| NCT04483102 | Recruiting | N/A | RESTORE Declined Livers Study | December 3, 2020 | September 2026 |
| NCT04490330 | Recruiting | Screening for Alcohol-related Cognitive Impairments in Cirrhotic Patients | August 1, 2020 | August 2023 | |
| NCT04551742 | Recruiting | Social & Contextual Impact on Children Undergoing Liver Transplantation | September 16, 2020 | December 2024 | |
| NCT04556019 | Recruiting | Results of Surgical Treatment of the Hepatobiliopancreatic Surgical Unit | January 3, 2019 | January 2029 | |
| NCT04613921 | Recruiting | Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs | July 8, 2021 | December 31, 2026 | |
| NCT04764305 | Recruiting | Liver Disease, Myocardial Fibrosis and Collaterals in the Adult Fontan Patient a Metabolomics and Proteomics Approach | April 1, 2022 | December 31, 2025 | |
| NCT04965259 | Recruiting | Early Detection of Hepatocellular Carcinoma in a High-risk Prospective Cohort (ELEGANCE) | April 15, 2021 | February 21, 2025 | |
| NCT05191446 | Recruiting | N/A | Coronavirus Disease 2019 (Covid-19) Impact on Alcohol-related Liver Disease Patient Outcomes, Care and Alcohol Use | February 1, 2022 | February 27, 2026 |
| NCT05196867 | Recruiting | N/A | Liver Cancer Prevention Randomized Control Trial | February 11, 2022 | August 30, 2025 |
| NCT05234190 | Recruiting | Phase 1/Phase 2 | Safety and Clinical Activity of QEL-001 in A2-mismatch Liver Transplant Patients | January 21, 2022 | March 2040 |
| NCT05255042 | Recruiting | Tissue Models for Liver Disease | September 8, 2021 | December 31, 2025 | |
| NCT05264051 | Recruiting | MAsS Scan as a Predictor of Morbidity and Mortality in Patients With Liver Disease | April 18, 2022 | March 1, 2027 | |
| NCT05272319 | Recruiting | Genetic Collection Protocol | April 6, 2022 | May 31, 2024 | |
| NCT05339984 | Recruiting | N/A | Hepatic and Systemic Hemodynamic Modeling During Liver Surgery | January 3, 2023 | June 1, 2025 |
| NCT05352152 | Recruiting | Application of NGS in Ascites Infection | July 1, 2022 | April 25, 2023 | |
| NCT05385237 | Recruiting | N/A | Identification of Hepatic Fibrosis Using 4D-MRI | August 1, 2021 | December 31, 2024 |
| NCT05443581 | Recruiting | N/A | The Effect of Vegetarian Diet on Patients With Metabolic Associated Fatty Liver Disease | July 1, 2022 | May 2024 |
| NCT05457114 | Recruiting | Association Between the Use of Pulmonary Artery Catheter and Clinical Outcomes After Liver Transplantation | May 1, 2022 | December 31, 2022 | |
| NCT05457543 | Recruiting | Blood Collection for Development and Validation of Point-of-Care Diagnostic Liver Function Tests | June 30, 2022 | March 2023 | |
| NCT05470205 | Recruiting | Phase 3 | Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension; Renewal | November 28, 2022 | April 30, 2026 |
| NCT05499585 | Recruiting | N/A | Treating Pediatric NAFLD With Nutrition | September 12, 2022 | October 2024 |
| NCT05567328 | Recruiting | N/A | Validation of the New Vibration-guided FibroScan Examination | October 26, 2022 | December 2024 |
| NCT05733832 | Recruiting | N/A | A Trial of Post-Discharge Transitional Care for Patients With Chronic Liver Disease | September 1, 2023 | June 30, 2028 |
| NCT05770284 | Recruiting | N/A | Effect of Exercise Based Regimen on Frailty in Children With Liver Disease | March 15, 2023 | February 14, 2025 |
| NCT05900037 | Recruiting | N/A | GATT-Patch Versus SURGICEL® Original in Minimally Invasive Liver and Gallbladder Surgery | October 6, 2023 | December 2024 |
| NCT05912179 | Recruiting | Prospective Single Centre Observational Study to Compare the Diagnostic Yield of Different Modalities of Liver Biopsy | September 1, 2022 | September 30, 2023 | |
| NCT05931068 | Recruiting | Perioperative Energy Expenditure in Major Liver Resection | May 1, 2023 | August 31, 2024 | |
| NCT05935488 | Recruiting | Early Liver Disease Breath Detection | May 21, 2024 | June 2024 | |
| NCT06061276 | Recruiting | N/A | bTAE-HAIC Combined With System Therapy for Intermediate-advanced Huge HCC | May 20, 2024 | December 30, 2025 |
| NCT06070636 | Recruiting | N/A | bTAE-HAIC Combined With Lenvatinib and Sintilimab for Infiltrative Hepatocellular Carcinoma | May 20, 2024 | June 30, 2025 |
| NCT06072287 | Recruiting | The Living With a Long-Term Condition Study | June 28, 2023 | January 10, 2024 | |
| NCT06152250 | Recruiting | N/A | Characterization of the Intrahepatic Inflammatory Microenvironment in Patients With Non-alcoholic Steatohepatitis | January 29, 2023 | January 29, 2026 |
| NCT06195917 | Recruiting | N/A | Robotic-assisted Percutaneous Transhepatic Puncture | September 19, 2023 | May 1, 2024 |
| NCT06272058 | Recruiting | Phase 1 | A Study to Test How Avenciguat (BI 685509) is Taken up in the Body of People With and Without Liver Problems | March 20, 2024 | October 1, 2024 |
| NCT06278883 | Recruiting | N/A | Genomic Medicine Risk Assessment Care for Everyone - Implementation Phase | June 3, 2024 | June 30, 2025 |
| NCT06298604 | Recruiting | N/A | Motorized Fine Needle Biopsy vs Standard Needles | December 9, 2023 | December 9, 2024 |
| NCT06319222 | Recruiting | N/A | Implementation of a Digital Clinic for Alcohol-associated Liver Disease and Alcohol Use Disorder (DALC) | March 12, 2024 | April 2025 |
| NCT06336018 | Recruiting | Phase 1 | A Research Study on Etavopivat in Participants With and Without Liver Disease | June 4, 2024 | September 4, 2025 |
| NCT06336850 | Recruiting | N/A | Safety and Efficacy of Endoscopic Ultrasound-Guided Portal Pressure Gradient Measurement | December 23, 2020 | January 1, 2025 |
| NCT06340347 | Recruiting | Phase 1 | A Study to Learn How the Body Processes the Study Medicine Called Osivelotor (PF-07940367) in People With Loss of Liver Function | April 30, 2024 | September 9, 2025 |
| NCT00571272 | Suspended | Longitudinal Study of Genetic Causes of Intrahepatic Cholestasis (LOGIC) | November 30, 2007 | May 2029 | |
| NCT00734136 | Terminated | N/A | Role Of Angiogenic Factors In The Development Of Hepatorenal Syndrome | May 2005 | February 2009 |
| NCT00436722 | Terminated | Phase 2 | Induction Treatment Followed by Immunosuppression Withdrawal in Liver Transplantation: A Comparative Trial | June 2006 | |
| NCT02613403 | Terminated | Phase 2 | Efficacy and Safety of Grazoprevir (+) Uprifosbuvir (+) Ruzasvir (MK-3682B) (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021) | December 10, 2015 | March 27, 2017 |
| NCT00031135 | Terminated | Phase 2 | Total Parenteral Nutrition-Associated Liver Disease | September 2001 | September 2005 |
| NCT01009593 | Terminated | Phase 3 | Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC) | January 2010 | July 2012 |
| NCT01461889 | Terminated | Phase 3 | INR-Triggered Transfusion In GI Bleeders From ER | July 2011 | August 2015 |
| NCT03265249 | Terminated | N/A | BRIDGE Device for Post-operative Pain Control | February 12, 2018 | April 3, 2020 |
| NCT00068094 | Terminated | Phase 1/Phase 2 | The Effect of Good Bacteria on Nonalcoholic Fatty Liver Disease in Diabetics | July 2005 | February 2006 |
| NCT05765253 | Terminated | N/A | Achieving Portal Access With Scorpion Post-Approval Study (APASS) | July 13, 2023 | November 19, 2023 |
| NCT03022630 | Terminated | N/A | Palliative Care for Non-Malignant Diseases (COMPASS Trial) | February 6, 2017 | June 21, 2018 |
| NCT03479125 | Terminated | Post-Treatment Follow-up Study for Liver Disease Subjects With or Without Cirrhosis After Receiving Emricasan or Placebo | February 27, 2018 | September 30, 2019 | |
| NCT05790109 | Terminated | N/A | Operator and Patient Acceptance of Radiofrequency Cautery of the Biopsy Track During Percutaneous Liver, Kidney or Spleen Biopsy Procedures. | May 23, 2023 | June 30, 2023 |
| NCT03396705 | Terminated | Liver Regeneration | September 12, 2017 | March 19, 2019 | |
| NCT03800069 | Terminated | Validation of Point of Care Liver Function Tests | December 3, 2018 | May 30, 2019 | |
| NCT05282121 | Terminated | Phase 2 | A Study to Test Whether BI 685509 Alone or in Combination With Empagliflozin Helps People With Liver Cirrhosis Caused by Viral Hepatitis or Non-alcoholic Steatohepatitis (NASH) Who Have High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver) | May 26, 2022 | June 7, 2024 |
| NCT00678587 | Terminated | Phase 3 | Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures | June 2008 | October 2009 |
| NCT02949492 | Terminated | Phase 4 | Low-dose IL-2 for Treg Expansion and Tolerance (LITE) | December 12, 2017 | January 31, 2019 |
| NCT05184283 | Terminated | Utilization of MAsS in Patients Undergoing LT for HCC | June 16, 2022 | November 29, 2023 | |
| NCT02208804 | Unknown status | Phase 2/Phase 3 | Surefire Infusion System vs. Standard Microcatheter Use During Holmium-166 Radioembolization | November 2014 | |
| NCT00450398 | Unknown status | Phase 2 | YSPSL for Prevention of Delayed Graft Function in Cadaveric Liver Transplantation | March 2007 | February 2008 |
| NCT00771888 | Unknown status | Phase 2/Phase 3 | Open-Label Extension of LOCKCYST Trial | April 2008 | August 2009 |
| NCT01760148 | Unknown status | Patterns of Early Hepatitis C Virus Decline Predict the Outcome of Interferon Therapy (sIFN-pred2) | July 2012 | March 2014 | |
| NCT01567631 | Unknown status | N/A | Classical Procedure Versus Intrahepatic Glisson's Approach | January 2012 | December 2017 |
| NCT01556815 | Unknown status | Phase 2 | Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma | May 2012 | May 2015 |
| NCT01533324 | Unknown status | Phase 2 | S-1/LV One Week on and One Week Off Regimen in Advanced Hepatocellular Carcinoma (HCC) | November 2011 | December 2016 |
| NCT00247117 | Unknown status | N/A | Metformin in Patients With Non-Alcoholic Fatty Liver Disease (NAFLD) | January 2004 | August 2005 |
| NCT01429779 | Unknown status | Phase 4 | The Orange-III Trial: Optimised Recovery With Movicol® Preoperatively Within an Enhanced Recovery Programme | July 2012 | |
| NCT04191018 | Unknown status | GastrOesophageal Varices After Sustained Virological Response | November 26, 2019 | February 28, 2024 | |
| NCT04154696 | Unknown status | N/A | APHP Plateform of Normothermic Perfusion for Rehabilitation of Hepatic Grafts | October 28, 2019 | April 1, 2022 |
| NCT04245319 | Unknown status | N/A | Combined Effect of Acitretin and Narrow Band Ultraviolet B on Vitiligo Repigmentation | January 1, 2020 | December 1, 2021 |
| NCT04100304 | Unknown status | N/A | Preoperative Evaluation of the Remaining Part of the Liver for Liver Resection | October 1, 2019 | July 30, 2022 |
| NCT04073290 | Unknown status | Phase 4 | Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and Lactulose | January 21, 2020 | September 30, 2023 |
| NCT00005667 | Unknown status | Vancomycin Resistant Enterococci in Patients Awaiting Liver Transplantation at the University of Michigan: Prevalence, Risk Factors, Natural History and Outcome of Colonization | |||
| NCT04446156 | Unknown status | Liver Diseases in PLWH | May 26, 2020 | December 30, 2020 | |
| NCT01220986 | Unknown status | Liver Regeneration After Liver Resection | August 2010 | August 2012 | |
| NCT04896723 | Unknown status | Sexual Dysfunction in Patients With Chronic Liver Disease | June 1, 2021 | May 31, 2022 | |
| NCT04924595 | Unknown status | N/A | Exercise Intervention in Liver Transplant Candidates | April 25, 2021 | December 31, 2021 |
| NCT03274388 | Unknown status | N/A | Whole Body Electromyostimulation and Nutritional Therapy for Patients With Chronic Liver Disease | January 1, 2017 | December 2019 |
| NCT03234543 | Unknown status | N/A | Remote Ischemic Conditioning in Abdominal Surgery | October 8, 2017 | June 15, 2020 |
| NCT03172650 | Unknown status | Effect of Non-alcoholic Fatty Liver Disease on Kidney Functions | July 1, 2017 | September 2018 | |
| NCT05007665 | Unknown status | Safety and Immune Response of COVID-19 Vaccination in Patients With Chronic Liver Diseases | July 1, 2021 | December 30, 2023 | |
| NCT03074708 | Unknown status | N/A | Application of 3D Visualization and 3D Printing in the Hepatobiliary and Pancreatic Surgery | March 2017 | December 2018 |
| NCT03063866 | Unknown status | Phase 4 | Randomised Controlled Study of Popofol Versus Midazolam as Sedation in Endoscopy With Advanced Liver Disease. | February 21, 2017 | April 2018 |
| NCT05054712 | Unknown status | Prevalence of Metabolic Liver Diseases in Patients With Type 1 Diabetes Mellitus | September 1, 2021 | January 1, 2024 | |
| NCT05088044 | Unknown status | N/A | A Study to Assess the Impact of Implementing Modified Early Warning Score in Terms of Competency and Self-efficacy of Nurses at ILBS, Delhi | November 11, 2021 | April 15, 2022 |
| NCT05120557 | Unknown status | N/A | Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASH | September 2022 | September 2023 |
| NCT02943707 | Unknown status | Phase 2 | Autologous Bone Marrow Stem Cells Infusion for the Treatment of Liver Diseases. | October 2016 | October 2020 |
| NCT02764671 | Unknown status | Phase 4 | Safety and Immunogenicity of Recombinant Hepatitis B Vaccines in the Neonates | May 2015 | September 2020 |
| NCT02758977 | Unknown status | N/A | Associating Liver Partition With Portal Vein Ligation for Staged Hepatectomy (ALPPS) vs. Two-Stage Hepatectomy (TSH) for Marginally Resectable Colorectal Liver Metastases (CRLM) | May 2016 | |
| NCT02647047 | Unknown status | N/A | Spinal Versus Epidural Analgesia in Laparotomic Liver Surgery | January 2016 | December 2016 |
| NCT00815464 | Unknown status | N/A | A Single-Arm Study Evaluating the Efficacy of Liquid Acupuncture Therapeutics in Chronic Hepatitis B | March 2009 | March 2010 |
| NCT05204602 | Unknown status | Safety and Immunogenicity of COVID-19 Vaccine Booster in Patients With Liver Diseases | February 10, 2022 | December 20, 2022 | |
| NCT02542020 | Unknown status | Prospective Evaluation of HIV Patients Using Non-invasive Methods for Estimation of Liver Fibrosis and Steatosis | June 2015 | May 2022 | |
| NCT04718051 | Unknown status | Phase 4 | S.P.PRO LIVER POWDER is Used to Improve Liver and Metabolic Indexes in People With Non-alcoholic Fatty Liver Disease | January 13, 2021 | December 31, 2021 |
| NCT03552367 | Unknown status | N/A | Structured Exercise Prescription Program in Obese Children | December 1, 2017 | July 31, 2020 |
| NCT04750031 | Unknown status | Pain Scores and Complications do Not Differ at Three Recovery Position After Liver Biopsy | January 1, 2018 | March 1, 2021 | |
| NCT03509194 | Unknown status | Better Diagnostic Tools for Children and Adolescents With Acute Liver Failure and Chronic Liver Insufficiency | December 17, 2017 | December 17, 2020 | |
| NCT03487159 | Unknown status | N/A | Using the Non Invasive Technology Magnetic Resonance Elastography for the Diagnosis of Liver Fibrosis Stage | May 1, 2018 | June 1, 2019 |
| NCT03434639 | Unknown status | Fluorescence Spectroscopy for Gut Permeability Assessment | March 29, 2019 | September 30, 2021 | |
| NCT03416387 | Unknown status | N/A | Applicability of 3D Printing and 3D Digital Image Reconstruction in the Planning of Complex Liver Surgery (LIV3DPRINT). | June 23, 2017 | June 1, 2018 |
| NCT03883789 | Unknown status | Defining 'Normal' Liver Function Tests & FibroScan Values in Pregnancy | April 1, 2019 | November 1, 2020 | |
| NCT04463745 | Unknown status | Organ Dysfunction Associated With Intra Abdominal Pressures in Liver Transplantation | July 15, 2020 | June 30, 2021 | |
| NCT03837197 | Unknown status | N/A | Clinical Trial of New Hypothermic Oxygenated Perfusion System Versus Static Cold Storage | December 21, 2018 | December 2021 |
| NCT03811431 | Unknown status | N/A | Contrast Enhanced Ultrasound Guidance Biopsy for the Diagnosis of Liver Tumors | January 1, 2011 | January 1, 2020 |
| NCT01423708 | Unknown status | Phase 2 | Everolimus in de Novo Liver Transplantation: a Multicentre Randomized Study | February 2010 | January 2014 |
| NCT00163995 | Unknown status | Urotensin II and Vascular Tone in Cirrhosis | |||
| NCT01279356 | Unknown status | Volatile Organic Compounds (VOCs) and Liver Diseases | February 2011 | August 2012 | |
| NCT04518852 | Unknown status | Phase 2 | TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC | September 14, 2020 | January 31, 2023 |
| NCT04525833 | Unknown status | Liver Disease and Other Systemic Diseases | January 1, 2020 | December 31, 2021 | |
| NCT04535440 | Unknown status | To Describe the Clinical, Endoscopic and Endoscopic Ultrasound Features of Non-bleeding and Bleeding Rectal Varices, Among Patients With Portal Hypertension | January 7, 2021 | July 31, 2022 | |
| NCT04863144 | Unknown status | Pharmacokinetics of Paclitaxel in Correlation With Adverse Events in Cancer Patients With and Without Liver Impairment | August 1, 2020 | February 1, 2022 | |
| NCT03777293 | Unknown status | N/A | A Prospective Study to Monitor Liver Diseases Dynamically by Ultrasound Viscoelasticity | January 1, 2019 | January 1, 2023 |
| NCT04631965 | Unknown status | Healthcare Transition of Adolescents With Chronic Health Conditions | September 1, 2017 | December 2023 | |
| NCT03776760 | Unknown status | Strategies for Hepatitis C Testing and Treatment in Aboriginal Communities That Lead to Elimination | May 28, 2019 | August 2022 | |
| NCT04640116 | Unknown status | N/A | TIPS Combined With Microwave Ablation in HCC Patients With Refractory Ascites | February 1, 2021 | June 30, 2023 |
| NCT03766633 | Unknown status | Accuracy of the LiverVision® Semi-automated Liver Volumetry Software | April 29, 2018 | March 31, 2021 | |
| NCT03743272 | Unknown status | Repeatability and Reproducibility of Multiparametric MRI | June 3, 2017 | November 1, 2022 | |
| NCT03620916 | Unknown status | N/A | Comparison of Intrathecal and Intravenous Analgesia in Patients Undergoing Liver Resection | August 17, 2018 | January 2019 |
| NCT04701567 | Unknown status | Diagnostic and Evaluation of Hepato-pancreatico-biliary Disease With MRI | June 30, 2020 | December 30, 2023 | |
| NCT04437953 | Withdrawn | Phase 2 | Avatrombopag for Thrombocytopenia in People With Cancer | May 27, 2020 | December 3, 2020 |
| NCT00062543 | Withdrawn | Phase 1 | Hepatic Artery Infusion of CD34+ Cells | May 2002 | October 2005 |
| NCT04021264 | Withdrawn | Phase 2/Phase 3 | The Impact of an Epidural Anesthetic on the Consumption of Sevoflurane in Major Abdominal Surgery | August 1, 2019 | January 1, 2022 |
| NCT02997098 | Withdrawn | Longitudinal Outcomes in Hepatic Resection | May 4, 2017 | May 2037 | |
| NCT03399227 | Withdrawn | Liver Transplantation: Skeletal Effects | June 1, 2020 | March 31, 2023 | |
| NCT03969199 | Withdrawn | N/A | Give a MANNA a Fish, Teach a MANNA to Fish | December 2023 | July 2024 |
| NCT01062659 | Withdrawn | Cellular Immune Responses in the Liver in Chronic Hepatitis C (CHC) Patients | February 2010 | March 2013 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D008107